Trials / Completed
CompletedNCT05890833
The Risk of Falls Index for Patients With Neuromuscular Disorders
The FBIndex to Determine the Risk of Falls and Its Translation to Assistive Gait Device Care for Patients With Neuromuscular Disorders
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- LMU Klinikum · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The combination of short quantitatively assessing muscular function and balance in combination with short clinical scores, can be a new valid approach to evaluate the patient risk of fall and help to create a quick checkup test to prescribe an appropriate assistive device. The primary goal of this project is to provide a short battery of clinical assessments used to determine risk of falling for patients with neuromuscular diseases (NMD) based on correlation between clinical assessments between two groups of NMD patients and scales used to assess risk of falling for patients.
Conditions
- Inclusion Body Myositis
- Myotonic Dystrophy
- Facioscapulohumeral Muscular Dystrophies
- Myasthenia Gravis
- The Falls Efficacy Scale International
- The Morse Fall Scale
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | The risk of falls | Heel-Rise-Test, Chair-Rise Test, Semi-tandem stand, Trunk Rise Test, and Foot-tapping speed. Test battery two includes Timed Up and Go test, 10 Meter Walk Test, Six Minute Walk test, The Falls Efficacy Scale International FES-I, The Morse Fall Scale. |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2024-09-09
- Completion
- 2024-09-09
- First posted
- 2023-06-06
- Last updated
- 2024-09-19
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05890833. Inclusion in this directory is not an endorsement.